TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T86646	HUMAN beta adrenergic receptor	B63CPB	1-[4-[4-(Methylsulfonylamino)phenyl]-1-piperazinyl]-3-(4-acetylaminophenoxy)-2-propanol	Investigative	14739899	C22H30N4O5S	462.6	CC(=O)NC1=CC=C(C=C1)OCC(CN2CCN(CC2)C3=CC=C(C=C3)NS(=O)(=O)C)O	IC50 = 293000 nM	Non binder
T86646	HUMAN beta adrenergic receptor	B6IOT7	N-[4-[1-Hydroxy-2-(3-methylimidazol-3-ium-1-yl)ethyl]phenyl]methanesulfonamide;chloride	Investigative	9818958	C13H18ClN3O3S	331.82	C[N+]1=CN(C=C1)CC(C2=CC=C(C=C2)NS(=O)(=O)C)O.[Cl-]	IC50 = 2350000 nM	Non binder
T86646	HUMAN beta adrenergic receptor	B7K5PI	Sematilide	Investigative	58505	C14H23N3O3S	313.42	CCN(CC)CCNC(=O)C1=CC=C(C=C1)NS(=O)(=O)C	IC50 = 7000000 nM	Non binder
T86646	HUMAN beta adrenergic receptor	BB07RD	N-[2-[[2-Hydroxy-3-[4-(methanesulfonamido)phenoxy]propyl]amino]ethyl]-4-imidazol-1-ylbenzamide	Investigative	14739883	C22H27N5O5S	473.5	CS(=O)(=O)NC1=CC=C(C=C1)OCC(CNCCNC(=O)C2=CC=C(C=C2)N3C=CN=C3)O	IC50 = 227000 nM	Non binder
T86646	HUMAN beta adrenergic receptor	BE25AU	1-[4-(Methylsulfonylamino)benzoyl]-4-[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]piperazine	Investigative	14739887	C24H33N3O6S	491.6	COCCC1=CC=C(C=C1)OCC(CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C)O	IC50 = 360000 nM	Non binder